https://www.selleckchem.com/products/hg6-64-1.html
Cardiovascular diseases (CVDs) such as stroke, high blood pressure, peripheral vascular disease, ischemic heart disease and acute myocardial infarction are some of the leading causes of death. To treat CVDs, commercially available thrombolytic agents are widely used. However, these thrombolytic agents have various side effects. Alternatively, fibrinolytic enzymes from bacterial sources are highly safe and have direct blood clot lytic activity. A fibrinolytic enzyme producing bacterial strain, Bacillus flexus BF12, was isolated from a s
Like
Comment
Share
